feed,title,long_url,short_url
SeekingAlpha,GT Biopharma posts ROR1 TriKE prostate cancer pre-clinical results,https://seekingalpha.com/news/3670207,
SeekingAlpha,"Bitcoin roundup: Back over $50K post-stimulus, Norway's Aker wants in",https://seekingalpha.com/news/3670206,
SeekingAlpha,Vista Equity Partners increases take over price of Pluralsight to $22.50/share in cash,https://seekingalpha.com/news/3670204,
